Northern Trust Corp Quotient LTD Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.24 - $1.2 $132,789 - $663,946	-553,289 Reduced 77.53%	160,374 $38,000
Q1 2022 May 13, 2022	SELL	$0.94 - $2.38 $27,739 - $70,233	-29,510 Reduced 3.97%	713,663 $856,000
Q4 2021 Feb 08, 2022	SELL	$1.89 - $3.12 $199,642 - $329,568	-105,631 Reduced 12.44%	743,173 $1.93 Million
Q3 2021 Nov 15, 2021	SELL	$2.34 - $3.77 $40,343 - $64,998	-17,241 Reduced 1.99%	848,804 $1.99 Million
Q2 2021 Aug 13, 2021	BUY	$3.48 - $4.45 $152,044 - $194,424	43,691 Added 5.31%	866,045 $3.15 Million
Q1 2021 May 12, 2021	SELL	$3.57 - $6.2 $123,475 - $214,439	-34,587 Reduced 4.04%	822,354 $3.03 Million
Q4 2020 Feb 11, 2021	BUY	$4.4 - $7.32 $647,486 - $1.08 Million	147,156 Added 20.73%	856,941 $4.47 Million
Q3 2020 Nov 16, 2020	BUY	$4.38 - $8.35 $325,600 - $620,722	74,338 Added 11.7%	709,785 $3.65 Million
Q2 2020 Aug 14, 2020	BUY	$3.64 - $9.26 $2.24 Million - $5.69 Million	614,312 Added 2906.61%	635,447 $4.7 Million
Q1 2020 May 14, 2020	BUY	$2.54 - $9.38 $1,501 - $5,543	591 Added 2.88%	21,135 $83,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $60,342 - $81,167	8,535 Added 71.07%	20,544 $196,000
Q3 2019 Nov 13, 2019	SELL	$7.77 - $11.26 $7,801 - $11,305	-1,004 Reduced 7.72%	12,009 $94,000
Q2 2019 Aug 13, 2019	BUY	$7.91 - $10.25 $102,932 - $133,383	13,013 New	13,013 $122,000
Q2 2018 Aug 14, 2018	SELL	$3.93 - $8.93 $927,059 - $2.11 Million	-235,893 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.22 - $5.21 $25,180 - $31,088	-5,967 Reduced 2.47%	235,893 $1.17 Million
Q3 2017 Nov 13, 2017	BUY	$3.23 - $4.93 $781,207 - $1.19 Million	241,860	241,860 $1.19 Million

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.